COMMUNIQUÉS West-GlobeNewswire

Essilor : Nombre total de droits de vote et d'actions composant le capital social au 30 novembre 2017
05/12/2017
Nombre total de droits de vote et d'actions composant le capital social au 30 novembre 2017 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, [...]
In new survey of patients, Inspire examines clinical trials, genetic testing
05/12/2017
ARLINGTON, Va., Dec. 05, 2017 (GLOBE NEWSWIRE) -- In a new survey by Inspire, three of 10 respondents say they have talked to their doctors about enrolling in clinical trials, and about 14% actually participated in a [...]
AFA Invites Teens To Enter Its 2018 “Teens For Alzheimer’s Awareness” College Scholarship Essay Contest
05/12/2017
NEW YORK, Dec. 05, 2017 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA) is inviting high school seniors to take part in its 2018 “Teens for Alzheimer’s Awareness” College Scholarship Essay Contest. The [...]
RadNet, Inc. to Present at 10th Annual LD Micro Main Event Conference in Los Angeles on December 7th
05/12/2017
LOS ANGELES, Dec. 05, 2017 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]
Kalytera Confirms No Material Change in Operations
05/12/2017
SAN FRANCISCO and TEL AVIV, Israel, Dec. 05, 2017 (GLOBE NEWSWIRE) -- At the request of IIROC, Kalytera Therapeutics, Inc. (TSX-V: KALY ) (OTCQB:KALTF) (the " Company " or " Kalytera ") wishes to confirm that the [...]
ABILITY Network Helps Skilled Nursing Providers Streamline the Triple Check Process
05/12/2017
MINNEAPOLIS, Dec. 05, 2017 (GLOBE NEWSWIRE) -- ABILITY Network, a leading information technology company, today announced that it has added a powerful capability to its ABILITY | UBWATCH application to help streamline [...]
Texas Health IT company wants to make the US healthcare market competitive again
05/12/2017
HOUSTON, Dec. 05, 2017 (GLOBE NEWSWIRE) -- By creating a secure platform for people to store their health records and shop for medical providers, one new company out of Houston plans to revitalize the American [...]
RedHill Biopharma Provides 2017 Year-End Business Update
05/12/2017
TEL-AVIV, Israel and RALEIGH, N.C., Dec. 05, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Transactions concluded by management
05/12/2017
Olaine, 2017-12-05 15:21 CET (GLOBE NEWSWIRE) -- AS Olainfarm has received the notification of manager on transactions with securities issued by AS Olainfarm. The received notification is available in attachment. [...]
Adverum Biotechnologies Begins Patient Enrollment in the ADVANCE Phase 1/2 Clinical Trial for A1AT Deficiency
05/12/2017
-- Patients to Receive Single-administration of Gene Therapy Candidate ADVM-043 -- -- Company Expects to Report Preliminary Data in the Second Half of 2018 -- MENLO PARK, Calif., Dec. 05, 2017 (GLOBE NEWSWIRE) -- [...]
Chembio Receives $8.5 Million Commitment from Bio-Manguinhos to Purchase Components for Production of DPP® Assays in Brazil during 2018
05/12/2017
MEDFORD, N.Y., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has received an $8.5 million [...]
Mateon Announces Preclinical Data Indicating Enhanced Tumor Immune Response of CA4P with Checkpoint Inhibitor
05/12/2017
Addition of CA4P simultaneously reduces tumor volume and increases tumor white blood cells, T Cells and cytotoxic T Cells compared to anti-CTLA-4 monotherapy Preliminary data suggest immuno-oncology applications for [...]
CV Sciences, Inc. Repays Installment Obligation on Convertible Debt
05/12/2017
LAS VEGAS, Dec. 05, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it has paid the December 2017 installment obligation under its March 1, 2017 [...]
Novan Announces First Patient Dosed in Phase 1b Atopic Dermatitis Trial with SB414
05/12/2017
MORRISVILLE, N.C., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ) today announced that the first patient has been dosed in the Company's Phase 1b clinical trial to evaluate [...]
Antibacterial Benefits of PEKK for Orthopedic Applications Detailed in Study of 3D-Printed OsteoFab® Structures
05/12/2017
SOUTH WINDSOR, Conn., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM™), today announced the results [...]
Fortress Biotech Forms Subsidiary Tamid Bio to Develop Novel AAV Gene Therapies in Orphan Diseases With Unmet Medical Needs
05/12/2017
NEW YORK, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO ) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]
Sarepta Therapeutics Elects Biopharmaceutical Veteran, Michael W. Bonney, to its Board of Directors
05/12/2017
CAMBRIDGE, Mass., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]
100% of Prostate Cancer Patients Completing 31-Week Post-Therapy Exam After Treatment with OncBioMune Immunotherapy Show No Disease Progression
05/12/2017
BATON ROUGE, La., Dec. 05, 2017 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of a proprietary [...]
Galectin Therapeutics Announces Results from Phase 2b NASH-CX Trial
05/12/2017
Statistically significant and clinically meaningful effects observed in NASH cirrhosis patients without esophageal varices treated with GR-MD-02 Conference Call at 8:30 A.M. ET to Present Top Line Trial Results NORCROSS [...]

Pages